Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Adiponectin
100%
Lipolysis
100%
Insulin
100%
Interleukin-18 (IL-18)
100%
Intervention Studies
100%
Acipimox
100%
Serum Adiponectin
33%
Interleukin-6
33%
Insulin Infusion
33%
Lipodystrophy
33%
HIV-associated Lipodystrophy Syndrome
33%
Adipocyte
16%
Placebo
16%
Type 2 Diabetes Mellitus (T2DM)
16%
Inflammation
16%
Randomized Placebo-controlled Trial
16%
Non-diabetic
16%
Plasma Parameters
16%
Stable Isotopes
16%
Hyperinsulinemia
16%
Chronic Disease
16%
Crossover Design
16%
Low-grade Inflammation
16%
Basal Conditions
16%
Hyperinsulinemic-euglycemic Clamp
16%
Infusion Rate
16%
Abdominal Adiposity
16%
Low-dose Insulin
16%
Impaired Metabolism
16%
Acute Inhibition
16%
Causal Relationship
16%
Dose-dependent
16%
Patients with HIV
16%
Adiponectin Levels
16%
Lipolytic Effects
16%
Medicine and Dentistry
Adiponectin
100%
Intervention Study
100%
Lipolysis
100%
Insulin
100%
Interleukin 18
100%
Acipimox
100%
Tumor Necrosis Factor
28%
Placebo
28%
Interleukin 6
28%
Low Drug Dose
28%
Insulin Infusion
28%
Lipodystrophy
28%
Inflammation
28%
HIV-associated Lipodystrophy
28%
Cytokine
14%
Maturity Onset Diabetes of the Young
14%
Diabetes Mellitus
14%
Chronic Disease
14%
Stable Isotope
14%
Infusion Rate
14%
Abdominal Obesity
14%
Hyperinsulinemia
14%
Adipocyte
14%
Causal Relationship
14%
Pharmacology, Toxicology and Pharmaceutical Science
Adiponectin
100%
Intervention Study
100%
Interleukin 18
100%
Insulin
100%
Acipimox
100%
Fatty Acid
85%
Tumor Necrosis Factor
28%
Placebo
28%
Inflammation
28%
Interleukin 6
28%
Lipodystrophy
28%
HIV Associated Lipodystrophy
28%
Cytokine
14%
Diabetes Mellitus
14%
Hyperinsulinemia
14%
Chronic Disease
14%
Stable Isotope
14%
Abdominal Obesity
14%
Maturity Onset Diabetes of the Young
14%